cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Embecta Corp
3 own
3 watching
Current Price
$10.62
$0.27
(2.61%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,083.62M
52-Week High
52-Week High
32.00000
52-Week Low
52-Week Low
9.92500
Average Volume
Average Volume
0.58M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,083.62M
icon52-Week High32.00000
icon52-Week Low9.92500
iconAverage Volume0.58M
iconDividend Yield--
iconP/E Ratio--
What does the Embecta Corp do?
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Read More
How much money does Embecta Corp make?
News & Events about Embecta Corp.
PR Newswire
1 year ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC PR Newswire NEW YORK, Feb. 6, 2023 NEW YORK, Feb. 6, 2023 /PRNewswire/ -- Pomerantz LLP...
PR Newswire
1 year ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC PR Newswire NEW YORK, Jan. 19, 2023 NEW YORK, Jan. 19, 2023 /PRNewswire/ -- Pomerantz LLP...
PR Newswire
1 year ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC PR Newswire NEW YORK, Jan. 12, 2023 NEW YORK, Jan. 12, 2023 /PRNewswire/ --Pomerantz LLP...
Business Wire
1 year ago
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Embecta Corp. (Embecta or the Company) (NASDAQ: EMBC) on behalf of Embecta stockholders. Our investigation concerns whether Embecta has violated the federal securities...
Business Wire
1 year ago
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Embecta Corp. (Embecta or the Company) (NASDAQ: EMBC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or...
Frequently Asked Questions
Frequently Asked Questions
What is Embecta Corp share price today?
plus_minus_icon
Can Indians buy Embecta Corp shares?
plus_minus_icon
How can I buy Embecta Corp shares from India?
plus_minus_icon
Can Fractional shares of Embecta Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Embecta Corp stocks?
plus_minus_icon
What is today’s traded volume of Embecta Corp?
plus_minus_icon
What is today’s market capitalisation of Embecta Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Embecta Corp?
plus_minus_icon
What percentage is Embecta Corp down from its 52-Week High?
plus_minus_icon
What percentage is Embecta Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$10.62
$0.27
(2.61%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00